Specifically, activating mutations in the PI3K catalytic subunit α, encoded by the PIK3CA gene, is the most frequent oncogenic event in HNSCC, with 18.1 % of all HNSCC displaying PIK3CA mutations and 21.2 % of cases displaying PIK3CA gene copy number gain. Here, PIK3CA is linked to head and neck squamous cell carcinoma.